Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers

Florencia Pereyra, Janet Lo, Virginia A. Triant, Jeffrey Wei, Maria J. Buzon, Kathleen V. Fitch, Janice Hwang, Jennifer H. Campbell, Tricia H. Burdo, Kenneth C. Williams, Suhny Abbara, Steven K. Grinspoon

Research output: Contribution to journalArticlepeer-review

163 Scopus citations


HIV-1 elite controllers spontaneously maintain suppressed levels of viremia, but exhibit significant immune activation. We investigated coronary atherosclerosis by coronary computed tomography angiography (CTA) in elite controllers, nonelite controller, chronically HIV-1 infected, antiretroviral therapy (ART)-treated patients with undetectable viral load ('chronic HIV'), and HIV-negative controls. Prevalence of atherosclerosis (78 vs. 42%, P < 0.05) and markers of immune activation were increased in elite controllers compared with HIV-negative controls. sCD163, a monocyte activation marker, was increased in elite controllers compared with chronic HIV-1 (P < 0.05) and compared with HIV-negative controls (P < 0.05). These data suggest a significant degree of coronary atherosclerosis and monocyte activation among elite controllers.

Original languageEnglish (US)
Pages (from-to)2409-2412
Number of pages4
Issue number18
StatePublished - Nov 28 2012

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases


Dive into the research topics of 'Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers'. Together they form a unique fingerprint.

Cite this